Hospital Guide: Sir Run Run Shaw Hospital, Minimally Invasive Excellence in China
May 23, 2026
Sir Run Run Shaw Hospital (Zhejiang University), JCI-accredited, leads China in robotic surgery, with 80% of its procedures performed minimally invasively.
As Zhejiang's flagship JCI-accredited hospital and a national leader in robotic surgery, we blend cutting-edge technology with compassionate care, serving as a vital hub in the Yangtze River Delta's medical network.
Hospital Overview and Global Recognition
Legacy and scale: founded in 1994; more than 2,000 beds across the Qingchun (downtown) and Xiasha (suburban) campuses.
Accreditations: JCI certification (Joint Commission International) for quality and safety standards.
National "Double Center": among China's first Peripheral Vascular Intervention and Tumor Minimally Invasive Intervention (liver/lung) hubs (2023), the only one in Zhejiang.
Positioning: core member of Zhejiang University's medical alliance; 80% of surgeries minimally invasive, the highest in China.
Cutting-Edge Medical Technologies
Da Vinci Xi surgical system (4th generation): 10-15x magnified 3D vision, 540° rotating wrists, tremor filtration and sub-millimeter precision.
Milestone: single-system annual volume exceeds 1,000 cases (2020), ranking Top 3 nationally; the only Zhejiang hospital with two Da Vinci robots.
Innovations: the world's first robot-assisted single-port laparoscopic hepatectomy (2023); fluorescence-guided lymph node mapping for precision oncology.
M6 CyberKnife and hybrid ORs: for stereotactic radiosurgery and integrated image-guided interventions.
AI-driven radiology: United Imaging uDR systems with real-time patient monitoring and automated spinal/limb stitching for complex orthopedic cases.
CBCT-guided tumor embolization: reduces radiation exposure by 30% versus conventional methods.
Interventional breakthroughs: Yttrium-90 (⁹⁰Y) radioembolization for liver cancer; radial-access interventions minimizing patient discomfort.
Flagship Departments and Expert Teams
Minimally invasive oncology and interventional radiology: over 1,000 annual liver/lung interventions (e.g. ablation, particle implantation). Key tech: TIPS, PFA cardiac ablation and robotic low-rectal cancer surgery with 5% lower ostomy rates. Expert: Prof. Jiang Zhijun (蒋智军), a liver transplant pioneer, Director of Hepatobiliary Surgery, trained under Academician Zheng Shusen.
Urology and robotic surgery: over 2,500 robotic procedures (2015-2020), led by Prof. Ding Guoqing (丁国庆). Breakthrough: kidney-sparing tumor resection for deep-seated lesions (e.g. a 57-year-old patient case).
Respiratory and critical care: the Chen Enguo (陈恩国) team, national leaders in rare lung diseases, established a "Famous Physician Studio" in Yuhang District (2023).
Prof. Cai Xiujun (蔡秀军): Vice President; innovator of laparoscopic liver resection techniques; recipient of the National Technology Invention Award.
70% of senior surgeons trained at Mayo Clinic, Cleveland Clinic or European centers.
Hangzhou: Asia's Premier Med-Travel Hub
Visa facilitation: 240-hour visa-free transit for international travelers.
Medical fast-track: proposed by Zhejiang University medical leaders.
International Patient Services and Logistics
One-stop coordination: multilingual case managers (English/Japanese).
Cultural support: Halal/Kosher meals; interfaith prayer rooms.
Direct billing with AXA and Allianz.
Qingchun campus: address 3 Qingchun East Road, Hangzhou. Access: Metro Line 2, Qingchun Square Station (Exit C), with a direct underground link to the hospital lobby. From Xiaoshan Airport: Metro Line 7 to Line 2 (50 minutes); taxi (¥120).
Xiasha campus: address 368 Yanyu Road, Xiasha. Shuttle: 30-minute express bus from Qingchun campus; taxi from downtown (¥80).
Related Images
